Share Email Print
cover

Proceedings Paper

Photodynamic therapy of basal cell carcinoma with Levulon local application
Author(s): E. V. Filonenko; A. D. Kaprin; A. N. Urlova; N. I. Grigorievykh
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Topical 5-aminolevulinic acid-mediated photodynamic therapy is an established approach for the treatment of basal cell carcinoma. The study with 5- aminolevulinic acid drug Levulon was conducted in patients with superficial skin basal cell carcinoma. The study included 82 patients with overall number of tumor foci of 119. Tumor sites were as follows: head and neck, trunk, extremities. A photodynamic therapy session was performed using a laser with a wavelength of 630 nm, an energy density of 350 J/cm2. A complete response was recorded in 77 patients (114 foci) with an excellent cosmetic result. According to the analysis of survival in the group of patients with a complete response, the overall RFS was as follows: 1-year rate – 92.1%, 3-year – 88.3%. Photodynamic therapy with topical Levulon in patients with superficial BCC of the skin was effective and safe.

Paper Details

Date Published: 7 August 2019
PDF: 6 pages
Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 1107081 (7 August 2019); doi: 10.1117/12.2525825
Show Author Affiliations
E. V. Filonenko, P.A. Hertsen Moscow Oncology Research Ctr. (Russian Federation)
A. D. Kaprin, P.A. Hertsen Moscow Oncology Research Ctr. (Russian Federation)
A. N. Urlova, P.A. Hertsen Moscow Oncology Research Ctr. (Russian Federation)
N. I. Grigorievykh, P.A. Hertsen Moscow Oncology Research Ctr. (Russian Federation)


Published in SPIE Proceedings Vol. 11070:
17th International Photodynamic Association World Congress
Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?
close_icon_gray